Fig 3. Prevalence of antimicrobial resistance to folate pathway inhibitors exhibits a decreasing linear trend from 2002–2016.

However, no significantly higher odds for resistance to folate pathway inhibitors for the 2002–2009 period when compared to the 2010–2016 period (OR: 1.18, 95% CI: 0.50–2.76).